Cullinan Oncology Inc’s filing revealed that its Chief Business Officer Savill Corrine unloaded Company’s shares for reported $0.65 million on Feb 01 ’24. In the deal valued at $16.18 per share,40,000 shares were sold. As a result of this transaction, Savill Corrine now holds 165,990 shares worth roughly $2.87 million.
Then, Savill Corrine sold 40,000 shares, generating $563,600 in total proceeds. Upon selling the shares at $14.09, the Chief Business Officer now owns 165,990 shares.
Before that, Savill Corrine sold 21,316 shares. Cullinan Oncology Inc shares valued at $265,597 were divested by the Chief Business Officer at a price of $12.46 per share. As a result of the transaction, Savill Corrine now holds 165,990 shares, worth roughly $2.87 million.
William Blair initiated its Cullinan Oncology Inc [CGEM] rating to an Outperform in a research note published recently. A number of analysts have revised their coverage, including Wedbush’s analysts, who began to cover the stock in mid February with a ‘”an Outperform”‘ rating. TD Cowen began covering CGEM with “an Outperform” recommendation on June 15, 2023. BTIG Research started covering the stock on November 21, 2022. It rated CGEM as “a Buy”.
Price Performance Review of CGEM
On Tuesday, Cullinan Oncology Inc [NASDAQ:CGEM] saw its stock jump 4.65% to $17.32. Over the last five days, the stock has gained 1.70%. Cullinan Oncology Inc shares have risen nearly 69.97% since the year began. Nevertheless, the stocks have risen 72.85% over the past one year. While a 52-week high of $19.68 was reached on 04/16/24, a 52-week low of $7.64 was recorded on 01/11/24. SMA at 50 days reached $17.32, while 200 days put it at $11.86. A total of 3.35 million shares were traded, compared to the trading of 0.19 million shares in the previous session.
Levels Of Support And Resistance For CGEM Stock
The 24-hour chart illustrates a support level at 15.92, which if violated will result in even more drops to 14.52. On the upside, there is a resistance level at 19.67. A further resistance level may holdings at 22.02. The Relative Strength Index (RSI) on the 14-day chart is 54.16, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.25, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 71.90%. Stochastics %K at 28.90% indicates the stock is a holding.
